Issn Print: 0923-7534
Publication Date: 2018/03/01
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)
P Sharma; W E Barlow; A K Godwin; H Pathak; K Isakova; D Williams; K M Timms; A R Hartman; R J Wenstrup; H M Linden; D Tripathy; G N Hortobagyi; D F Hayes
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.